Pemafibrate for primary biliary cholangitis with dyslipidemia: A proposal of a new treatment from Japan

Hepatol Res. 2022 Jun;52(6):495-496. doi: 10.1111/hepr.13770.

Naoki Tanaka^{1

2

3}, Akira Honda^{4

5}

¹ Department of Global Medical Research Promotion, Shinshu University Graduate School of Medicine, Matsumoto, Japan.
² International Relations Office, Shinshu University School of Medicine, Matsumoto, Japan.
³ Research Center for Social Systems, Shinshu University, Matsumoto, Japan.
⁴ Division of Gastroenterology and Hepatology, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan.
⁵ Joint Research Center, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan.

No abstract available

Keywords: pemafibrate; primary biliary cholangitis; selective PPARα modulator.

Publication types